Belvedere Trading LLC Tg Therapeutics, Inc. Put Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$15.48 - $35.0 $108,360 - $245,000
7,000 New
7,000 $173,000
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $35,571 - $83,993
7,100 Added 52.21%
20,700 $244,000
Q3 2022

Oct 26, 2022
BUY
$4.57 - $8.4 $30,619 - $56,280
6,700 Added 97.1%
13,600 $73,000
Q2 2022

Jul 21, 2022
BUY
$3.74 - $10.66 $25,806 - $73,554
6,900 New
6,900 $43,000

Others Institutions Holding TGTX

# of Institutions
336
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email